Research
Pipeline Co-Creation
From high-throughput data to foresight. Nexyra turns complexity into predictive clarity.
From high-throughput data to foresight. Nexyra turns complexity into predictive clarity.
Nexyra merges biomedical AI, biostatistics, and omics data science into co-created environments. We accelerate R&D pipelines with partners seeking to go beyond the standard, integrating knowledge, technology, and intellectual property to translate molecular hypotheses into real-world clinical outcomes.
Our differential impact on Nexyra
Co-Created Science, Singular Talent
At Nexyra, we don't hire talent: we cultivate it. Our team is comprised of hybrid profiles from bioinformatics, data science, biotechnology, and translational medicine, trained at elite institutions and with direct experience in clinical, academic, and industrial innovation. More than 35% have PhDs and experience in multicenter projects, allowing us to integrate critical thinking, analytical precision, and applied creativity.
Our partners don't access "services": they join scientific teams that share goals, metrics, and vision. Each partnership is designed to generate real transfer, not just technical transfer. That's why more than 85% of our clients repeat projects with Nexyra in less than 18 months.
Alliances with Vision, Not Just Contracts
Nexyra doesn’t just deliver projects — we enable collaborative ecosystems. Our approach is agile, adaptive, and long-term oriented: scientific feedback loops, continuous data integration, and flexible architectures to reprioritize goals based on evidence and opportunity.
We co-design engagement models with our partners, ranging from fee-for-service to hybrid structures including milestone-based incentives, shared licensing, or co-owned IP. Because real innovation requires alignment — not just technically, but strategically and humanly.
Together, we don’t just accelerate phases — we redefine trajectories.
Proprietary Technology, Actionable Science
Nexyra’s differentiating power lies in our platforms — designed to transform molecular complexity into predictive decision-making. We provide exclusive starting points: high-resolution multi-omic datasets, proprietary molecular cohorts, and statistical engines optimized to identify targets, predictive signatures, and actionable clinical biomarkers.
Through co-creation models, we integrate these assets with our partners’ strategic vision — be they startups, clinical centers, or pharmaceutical companies — building projects where data, IP, and innovation are aligned from day one. Our modular infrastructure scales seamlessly from exploratory research to preclinical validation and clinical design.
Our integrated value chain
From high-performance data generation to predictive data generation and more.
Necesitamos su consentimiento para cargar las traducciones
Utilizamos un servicio de terceros para traducir el contenido del sitio web que puede recopilar datos sobre su actividad. Por favor revise los detalles en la política de privacidad y acepte el servicio para ver las traducciones.